Open Beta
TREN
MetriLume
TREN

US marketsNGNE

SEC-sourced researchBeta

NGNE

Neurogene Inc.

Company comparison ↗

Data passport

CIK
0001404644
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 7, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 925,000.0000 USD; December 2025: 0.0000 USD925K USD0 USD0December 2024December 2025
NGNE · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2024925,000.0000Mar 24, 2026
December 20250.0000Mar 24, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20250.0000-90,351,000.0000-77,173,000.0000288,604,000.000023,717,000.0000Mar 24, 2026
December 2024925,000.0000-75,144,000.0000-70,603,000.0000335,730,000.000025,355,000.0000Mar 24, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$0December 2025Mar 24, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$925KDecember 2024Mar 24, 202610-K
Net incomeNetIncomeLoss-$90.35MDecember 2025Mar 24, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$77.17MDecember 2025Mar 24, 202610-K
Total assetsAssets$288.6MDecember 2025Mar 24, 202610-K
Total liabilitiesLiabilities$23.72MDecember 2025Mar 24, 202610-K

New filings

Explore methodology ↗